Safety and Quality > Our Work > Healthcare Associated Infection > Consultation on Clostridium difficile

The Commission has developed a discussion paper on Clostridium difficile infection in response to the reported increase in Clostridium difficile within Australia. The aim of the Clostridium difficile discussion paper is to seek advice from a range of stakeholders to assist in the development of strategies and priority actions to address Clostridium difficile infection in Australia.

Consultation

The paper includes 10 consultation questions associated with the key areas related to Clostridium difficile surveillance, technical mechanisms and research. Clinicians, especially people working in microbiology, infectious diseases and infection prevention and control are encouraged to be part of this consultation process.

Feedback on the Surveillance and Monitoring of Clostridium difficile Infection in Australia discussion paper may be provided online via the survey monkey link: https://www.surveymonkey.com/r/cdidiscussionpaper

Written submissions may be sent to:

Director of the National HAI Prevention Program

The Australian Commission on Safety and Quality in Health Care,

GPO Box 5480 Sydney NSW 2001

HAI@safetyandquality.gov.au

All submissions must be received by Friday, 5 June 2015.